ROCHE HLDG LTD SPONS Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 54 Posts
1 2 3 4
Rayno Biopharma Portfolio Update
Article By: Rod Raynovich Monday, February 20, 2017 11:00 PM EST
We have updated our biopharmaceuticals portfolio for the period ending February 17 2017. Large caps biopharma stocks have only begun to recover in 2017 after the 2016 earnings release.
In this article: BMY, RHHBY, IBB, BIIB, GILD, XBI, BLUE, FMI Also: AMGN, ABBV
Read
Roche: A Would-Be Dividend Aristocrat With A 3.5% Dividend Yield
Article By: SureDividend Tuesday, January 24, 2017 12:36 PM EST
Despite the Brexit vote and unfavorable currency markets, Roche continues to generate solid growth and offers a secure 3.5% dividend yield.
In this article: RHHBY Also: JNJ, PFE
Read
Data Presented At ACR, Bristol-Myers Inks Immuno-Oncology Deal
Article By: Arpita Dutt Friday, November 18, 2016 8:30 AM EST
Several companies were present at the annual meeting of the American College of Rheumatology (ACR) presenting data on approved as well as pipeline candidates. Bristol-Myers announced an immune-oncology deal.
In this article: AGN, BMY, JNJ, PFE, SNY, RHHBY, TEVA
Read
E Trump Triumphs
Article By: Vivian Lewis Wednesday, November 9, 2016 9:28 PM EST
Banks, pharmaceutical and biotech stocks, gold, raw materials, and the yen are up. Mexican stocks and the peso are way down but not as way down as they were overnight.
In this article: ABX, BLX, BMY, CRH, CX, CZZ, EC, GSK, JNJ, NVO, SLB, SC, TTM, VALE, VR, ALIZF, BAESY, BKSHF, BVNKF, CMDXF, FCGYF, OROCF, PDYPF, RHHBY, SAXPF, TMRAF, IBB, ALKS, FXY, GLD, TLT, FBASF, FXM, BNTC
Read
E Drugs, Finance, Cars, And Fuel
Article By: Vivian Lewis Tuesday, November 1, 2016 11:57 AM EST
SAP​ of Germany released a new enterprise routine productivity software system which helps deal with deliveries and the supply chain for companies using machine learning and pattern recognition to get human beings away from this boring process.
In this article: ALV, TTM, BHI, GE, ITRN, NVO, RHHBY, TEVA, OROCF
Read
E Global Roundup: Roche, Vale, Novo Nordisk, Teva, Benitec Et Al
Article By: Vivian Lewis Friday, October 21, 2016 7:05 PM EST
It is a low news day because everyone is still rubbing their eyes after the Third Debate.
In this article: RHHBY, VALE, GSK, NVO, TEVA Also: CZZ, BHP, CGEN, CAE, CAT, KUBTY, GLD, GNCGF, SLFPF, BNIKF
Read
Illumina Misses Revenue Forecast Causing Collateral Damage To Biotechs
Article By: Rod Raynovich Tuesday, October 11, 2016 11:00 PM EST
Illumina shares crashed 25% to $139, after a warning on third quarter sales. The global leader in DNA sequencing systems warned that revenues missed forecast and would be $607M, well short of earlier guidance of $625-$630M.
In this article: TMO, RHHBY, IBB, ILMN, PACB, QGEN, XBI, XLV, FMI
Read
Biotech Stocks Recovering From Last Week’s Free Fall
Article By: Rod Raynovich Wednesday, October 5, 2016 11:06 PM EST
The IBB closed up 0.88% today to $290.8 about 10 points lower than the intermediate resistance and 6 points above 9/29 lows hit the day of the 3% drop. The XBI is a bit more volatile but clearly outperforms the IBB over one month with support at $60.
In this article: DB, RHHBY, PRHSX, SHSAX, ALNY, ALXN, IBB, GILD, MYL, XBI, ABBV, BLUE, ITCI
Read
Top Stock Stories For Friday, Sept. 30
Article By: The Fly Friday, September 30, 2016 8:32 PM EST
Stocks on Wall Street regained the losses they'd suffered yesterday as the market reassessed whether the problems faced by Deutsche Bank are serious enough to warrant the stock's recent decline.
In this article: DB, LXK, RHHBY, REGN, CAMP, PTCT, OPHT, NTNX
Read
Rayno 2016 Life Science Portfolio Update
Article By: Rod Raynovich Thursday, September 29, 2016 8:14 PM EST
Biotech stocks are near their intermediate highs but still down in 2016 : IBB at $295 down 12.78% and the XBI​ at $67.80 down 3.42% YTD.
In this article: ALR, BMY, TMO, RHHBY, CPHD, IBB, ILMN, AMGN, GILD, XBI, ABBV, BLUE, FMI
Read
Stealth Biotech Rally With Momentum Rising
Article By: Rod Raynovich Wednesday, September 21, 2016 2:20 AM EST
Biotechs stocks continued on their slow but steady upward course headed toward August highs in the case of the IBB and breaking out with the smaller cap weighted XBI​.
In this article: AGN, RHHBY, ARIA, IBB, MDVN, SGEN, AMGN, CLVS, GILD, XBI, PBYI, ABBV, SRPT, AGIO, BLUE, TBRA
Read
Biotech Breakout Part 2: Hold Your Fire
Article By: Rod Raynovich Wednesday, August 10, 2016 9:21 PM EST
Biotech stocks have rallied about 20% since the Brexit bottom on June 27 so wait for some consolidation before adding new positions to your portfolio.
In this article: BMY, MRK, RHHBY, ALNY, IBB, INCY, MDVN, ALKS, BIIB, GILD, VRTX, XBI, ABBV, BLUE, FMI
Read
Biotech Breakout: Is The Bull Market Back?
Article By: Rod Raynovich Thursday, August 4, 2016 6:46 PM EST
The large cap weighted IBB broke through April 22 and June 2 resistance to hit $297 although still down 11.97% YTD. The more volatile XBI also broke through recent triple tops up 15.36% for the past 30 days although down 8.29% YTD.
In this article: BMY, SLW, RHHBY, IBB, MDVN, AAPL, BIIB, GDX, XBI, XLV, ABBV, BLUE, FMI
Read
Biotech Stocks Strike A Bullish Tone
Article By: Rod Raynovich Wednesday, July 27, 2016 8:24 PM EST
Biotech stocks continued to drive higher despite the earnings miss in Gilead Sciences and a lackluster overall market. A green screen dominated today with significant upward momentum since the Brexit bottom.
In this article: BMY, LLY, RHHBY, IBB, AMGN, BIIB, CELG, GILD, ABBV, BLUE, FMI, KDMN
Read
Biotech Rally Up 8% From Brexit Bottom: Rayno Biopharmaceutical Portfolio Update: July 11, 2016
Article By: Rod Raynovich Monday, July 11, 2016 10:21 PM EST
Technicals tell the story as the IBB hit a triple bottom near 240, then rose to 250 at BREXIT event.
In this article: BMY, RHHBY, IBB, QQQ, CELG, GILD, ABBV, BLUE
Read
Large Cap Biopharmaceuticals-Valuation Models 2016
Article By: Rod Raynovich Monday, July 4, 2016 1:41 AM EST
The biotech sector has underperformed the market because of the severe correction in August/September of 2015 followed by another downdraft in January 2016 all the result of “bubble” valuations.
In this article: BMY, RHHBY, FBIOX, ALXN, IBB, REGN, AMGN, BIIB, CELG, GILD, FBT, XBI, ABBV
Read
1 to 16 of 54 Posts
1 2 3 4